earnings
RX
NASDAQ · RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
Healthcare · Biotechnology
$3.31
Up+$0.02 (+0.61%)
Updated Aug 14, 2026, 3:54 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.83B
- P/E ratio
- -2.94
- Dividend yield
- 0.00%
- 52-week range
- $2.77 – $7.18
- Volume
- 10.7M
- Avg. volume
- 43.4M
Price performance
RXRX price history
1M range · 21 trading sessions · Daily adjusted prices
RXRX closed at $3.31 after 21 trading sessions, up 9.60% for the selected period.
- Last close
- $3.31
- Period change
- +9.60%
- Period low
- $2.89
- Period high
- $3.35
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $3.31 | $3.35 | $3.27 | $3.31 | 10.7M |
| Aug 12, 2026 | $3.37 | $3.38 | $3.26 | $3.29 | 10.31M |
| Aug 11, 2026 | $3.32 | $3.42 | $3.27 | $3.35 | 11.01M |
| Aug 10, 2026 | $3.20 | $3.36 | $3.19 | $3.29 | 14.03M |
| Aug 7, 2026 | $3.2541 | $3.265 | $3.18 | $3.22 | 9.36M |
| Aug 6, 2026 | $3.13 | $3.26 | $3.115 | $3.18 | 14.79M |
| Aug 5, 2026 | $3.08 | $3.23 | $3.01 | $3.17 | 17.46M |
| Aug 4, 2026 | $3.265 | $3.36 | $3.21 | $3.31 | 21.58M |
| Aug 3, 2026 | $3.03 | $3.20 | $3.00 | $3.18 | 14.72M |
| Jul 31, 2026 | $3.09 | $3.105 | $2.95 | $3.00 | 15.33M |
| Jul 30, 2026 | $2.99 | $3.04 | $2.95 | $3.04 | 10.41M |
| Jul 29, 2026 | $3.03 | $3.09 | $2.945 | $2.97 | 17.95M |
| Jul 28, 2026 | $2.975 | $3.05 | $2.86 | $3.05 | 24.4M |
| Jul 27, 2026 | $3.03 | $3.13 | $2.99 | $3.01 | 21.72M |
| Jul 24, 2026 | $3.04 | $3.09 | $2.92 | $2.96 | 16.53M |
| Jul 23, 2026 | $2.925 | $3.03 | $2.92 | $3.01 | 18.83M |
| Jul 22, 2026 | $3.04 | $3.07 | $2.97 | $2.98 | 15.21M |
| Jul 21, 2026 | $2.90 | $3.08 | $2.90 | $3.08 | 14.87M |
| Jul 20, 2026 | $2.945 | $2.955 | $2.84 | $2.89 | 20.81M |
| Jul 17, 2026 | $2.96 | $3.02 | $2.93 | $2.945 | 19.35M |
| Jul 16, 2026 | $3.25 | $3.27 | $2.975 | $3.02 | 40.17M |
Latest RXRX news
The latest Smart Investors Daily articles mentioning RXRX.
Stock researchResearch & News · Competitors
Loading stock research…